Abstract
Background Treatment intensity of end-of-life care is the degree of aggressiveness of medical care aimed at providing life-prolonging medical care to patients with serious life-limiting illnesses. This study aims to assess the demographic and health characteristics associated with older adults with serious life-limiting illnesses who received highly intense end-of-life care.
Methods For this cross-sectional analysis, we pooled the 2015 to 2019 Medicare claims data of adults 65 years and older who visited at least one of the 29 emergency departments (EDs) enrolled in the Primary Palliative Care for Emergency Medicine. We identified those with serious life-limiting illnesses using a Gagne score of seven or higher. Our outcome measure was treatment intensity, defined using acute care and intensive care unit (ICU) admissions. Acute care admission was measured as a binary variable and ICU admission was measured as a three-point nominal variable. The predictor variables were age, sex, race/ethnicity, and illness severity (Gagne score). To assess the odds of acute care and ICU admissions, we used a generalized estimating equation model and a multinomial regression model, respectively. We performed the same analyses among the population without serious life-limiting illnesses to observe differences in effect sizes of intense treatment.
Results Of the 301,083 older adults that visited one of the 29 EDs, 13% had serious life-limiting illnesses. Age was associated with 9% and 7% increased odds of acute care (95% CI: 1.04 – 1.14) and ICU (95% CI: 1.02 – 1.12) admissions. We reported significant associations by sex, race/ethnicity, and illness severity (Gagne score). The effect sizes of the observed association between measures of treatment intensity and the demographic and health characteristics were smaller among those with serious life-limiting illnesses compared to those without serious life-limiting illnesses.
Conclusion Older adults with serious life-limiting illnesses who present to the ED experience intense treatment. Identifying demographic and health characteristics associated with treatment intensity may inform the need for serious illness conversations in the ED.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The New York University Langone Health Institutional Review Board (IRB) gave ethical approval for this work (IRB ID: i18 00607).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
